# Non-tuberculous mycobacterial infective endocarditis in a tuberculosis-endemic region after recent cardiovascular procedures: a case series

**Authors:** Shohael Mahmud Arafat, Chowdhury Adnan Sami, Abed Hussain Khan, Sudip Kumar Banik, Md. Mizanur Rahman Khan, Lovely Barai

PMC · DOI: 10.1099/acmi.0.001130.v3 · Access Microbiology · 2026-02-19

## TL;DR

This case series describes three patients with non-tuberculous mycobacterial infective endocarditis following heart procedures, highlighting diagnostic challenges and poor outcomes.

## Contribution

The study presents a novel case series from a tuberculosis-endemic region, emphasizing the under-recognized risk of NTM-IE after cardiovascular procedures.

## Key findings

- Three patients with NTM-IE following recent cardiovascular procedures had poor clinical outcomes despite antimicrobial therapy.
- Diagnosis relied on repeated cultures and exclusion of tuberculosis, but species-level identification was not possible due to resource limitations.
- Mortality was high, underscoring the need for a combined medical-surgical approach in managing NTM-IE.

## Abstract

Background. Non-tuberculous mycobacterial infective endocarditis (NTM-IE) is an uncommon but increasingly recognized aetiology of culture-negative endocarditis, particularly in the context of healthcare exposure. Rapidly growing non-tuberculous mycobacteria (NTM) species present significant diagnostic and therapeutic challenges due to their indolent nature and clinical similarity to tuberculosis.

Case summary. We describe a case series of three patients with native valve infective endocarditis caused by rapidly growing NTM following recent percutaneous coronary intervention. All patients initially presented with prolonged fever and systemic inflammatory signs, and routine microbiological workup results were negative. The diagnosis was based on repeated blood and/or urine cultures with the detection of rapidly growing NTM, exclusion of Mycobacterium tuberculosis by PCR analysis and echocardiography demonstrating valvular vegetations. Cultures were performed on consecutive days at a single reference laboratory according to established protocols to reduce the risk of sample contamination. Species-level identification was not feasible because of limited resources. All patients received combination antimicrobial therapy guided by the available susceptibility data and expert consultation. Despite multidrug treatment, clinical outcomes were poor in these cases. Two patients died before definitive surgical intervention could be performed, and one patient died during the induction of the valve replacement surgery.

Conclusion. This case series highlights the difficulties in diagnosing NTM-IE and its high mortality rate. NTM infection should be considered in patients with chronic fever after invasive cardiovascular procedures or with prolonged culture-negative endocarditis. Medical therapy is frequently inadequate, and a combined medical–surgical approach may be necessary.

## Linked entities

- **Diseases:** infective endocarditis (MONDO:0000565), tuberculosis (MONDO:0018076)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** cardiac arrest (MESH:D006323), cough (MESH:D003371), Drug toxicity (MESH:D064420), weight loss (MESH:D015431), thrombocytopenia (MESH:D013921), Diabetes (MESH:D003920), pancytopenia (MESH:D010198), NTM pulmonary disease (MESH:D008171), renal tuberculosis (MESH:D014398), Valvular vegetation (MESH:D006349), haematologic malignancy (MESH:D009369), AMI (MESH:D009203), NTM infection (MESH:D007239), hepatosplenomegaly (MESH:C535727), NCC (MESH:D000088442), viral infections (MESH:D014777), NTM endocarditis (MESH:D059905), hypertension (MESH:D006973), cytopenias (MESH:D006402), death (MESH:D003643), connective tissue disease (MESH:D003240), bacteraemia (MESH:C531821), inflammation (MESH:D007249), leucopenia (MESH:C536227), sepsis (MESH:D018805), aortic valve disease (MESH:D000082862), Infectious Diseases (MESH:D003141), Disorders (MESH:D009358), fever (MESH:D005334), NTM-IE (MESH:C566577), NTM (MESH:D014390), Metabolic Disorders (MESH:D008659), fungal endocarditis (MESH:D009181), coronary artery disease (MESH:D003324), M. tuberculosis (MESH:D014376), DAMA (MESH:D019522), anaemia (MESH:D000743), chest pain (MESH:D002637), cardiac decompensation (MESH:D006333), autoimmune (MESH:D001327), dead (MESH:D001926), haemorrhages (MESH:D006470), febrile (MESH:D000071072), IE (MESH:D004696), ERS (MESH:C000719191)
- **Chemicals:** linezolid (MESH:D000069349), /RIF (MESH:D012293), Amikacin (MESH:D000583), macrolide (MESH:D018942), ceftazidime-avibactam (MESH:C000595613), azithromycin (MESH:D017963), clarithromycin (MESH:D017291), DAMA (-), creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mycobacterium tuberculosis (species) [taxon 1773], Pseudomonas aeruginosa (species) [taxon 287], Human immunodeficiency virus (species) [taxon 12721], Mycobacteroides abscessus (species) [taxon 36809], Mycobacteriales (order) [taxon 85007], Human immunodeficiency virus 1 (no rank) [taxon 11676], Mycobacterium tuberculosis complex (species group) [taxon 77643], Mycolicibacterium fortuitum (species) [taxon 1766]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919340/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919340/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919340/full.md

---
Source: https://tomesphere.com/paper/PMC12919340